Pharma News

SAN FRANCISCO—David Hung is the CEO who sold his company, Medivation, to Pfizer for $14 billion.

The US Food and Drug Administration (FDA) has granted a breakthrough therapy designation to Shire’s investigational treatment for cytomegalovirus (CMV) infection in transplant patien...

Before patients can take prescriptions to a pharmacy and get their medications, FDA has to approve drugs first.

Sanofi and Regeneron are boosting their investment in development programmes for the PD-1 antibody cemiplimab in oncology and dupilumab in Type 2 (tissue specific) allergic diseases.

Arvinas and Pfizer have signed a research collaboration and license agreement relating to the discovery and development of protein degradation drug candidates.

Shire announced on Monday it would drop its revenue target of $20 billion by 2020, citing increased competition from generics and rival drug companies.

U.

Lupin has added to its generics lineup with its version of Valeant Pharmaceuticals’ Ancobon (flucytosine) capsules.

Japan’s largest drugmaker Takeda Pharmaceutical (TYO.

Generic maker Leading Pharma recently completed a financing transaction for $40 million of growth capital.

CAMBRIDGE, Mass.

Cambridge, Mass.